|
Volumn 20, Issue 5, 2010, Pages 131-137
|
Renal disease in pregnancy
|
Author keywords
chronic kidney disease; dialysis; pregnancy; transplant
|
Indexed keywords
ALBUMIN;
ALISKIREN;
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
AMLODIPINE;
ANGIOTENSIN RECEPTOR ANTAGONIST;
AZATHIOPRINE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CREATININE;
CYCLOSPORIN;
DILTIAZEM;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HEMOGLOBIN;
HYDRALAZINE;
LABETALOL;
METHYLDOPA;
MINOXIDIL;
MOXONIDINE;
MYCOPHENOLIC ACID;
NIFEDIPINE;
PREDNISOLONE;
RAPAMYCIN;
RITUXIMAB;
SPIRONOLACTONE;
TACROLIMUS;
THIAZIDE DIURETIC AGENT;
THYMOCYTE ANTIBODY;
UNINDEXED DRUG;
URATE;
UREA;
VERAPAMIL;
ARTICLE;
BLOOD PRESSURE MEASUREMENT;
BLOOD PRESSURE REGULATION;
CHRONIC KIDNEY DISEASE;
DIABETES MELLITUS;
DRUG CONTRAINDICATION;
ECHOGRAPHY;
ELECTROLYTE BALANCE;
EVIDENCE BASED MEDICINE;
FEMALE;
FETUS OUTCOME;
FLUID BALANCE;
GLOMERULUS FILTRATION RATE;
HEMODIALYSIS;
HUMAN;
KIDNEY BIOPSY;
KIDNEY DISEASE;
KIDNEY FAILURE;
KIDNEY GRAFT REJECTION;
KIDNEY INJURY;
KIDNEY TRANSPLANTATION;
MATERNAL HYPERTENSION;
MATERNAL NUTRITION;
MEDICAL ASSESSMENT;
NEPHROTIC SYNDROME;
PARENT COUNSELING;
PATIENT CARE;
PATIENT MONITORING;
PERITONEAL DIALYSIS;
PHYSICIAN ATTITUDE;
POLYMERASE CHAIN REACTION;
PREECLAMPSIA;
PREGNANCY;
PREGNANCY OUTCOME;
PROGNOSIS;
PROTEINURIA;
RISK ASSESSMENT;
URINALYSIS;
|
EID: 77953480098
PISSN: 17517214
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ogrm.2010.02.006 Document Type: Article |
Times cited : (2)
|
References (4)
|